GlassScriptPhysician profile
William K Wong
NPI 1144270042
$40,329.96
in general payments reported to CMS, 2019-2025
33 companies · $6,489 in 2025
The $6,489 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,177 · 2020: $639 · 2021: $2,565 · 2022: $6,797 · 2023: $7,989 · 2024: $9,673 · 2025: $6,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,250 · Travel and Lodging: $3,325 · Long Term Medical Supply Or Device Loan: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,737.76 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,250.00 |
| Travel and Lodging | $3,325.33 |
| Long Term Medical Supply Or Device Loan | $838.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $11,159.86 | 2022-2025 | Envista Mx60 Iol, Envista Aspire Iol, Vyzulta |
| Alcon Vision LLC | $7,576.91 | 2019-2025 | Lensx, Unity, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $3,834.77 | 2019-2025 | Tecnis Iol, Tecnis Iol, Catalys System |
| Glaukos Corporation | $3,512.13 | 2019-2025 | Idosetr, Istent Infinite Trabecular Micro-Bypass System Model Is3, Istent Infinite |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,991.55 | 2019-2021 | |
| Abbvie INC. | $1,846.84 | 2022-2025 | Xen Glaucoma Treatment System, Durysta, Alphagan P |
| Sight Sciences, INC. | $1,482.76 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Amgen INC. | $1,269.80 | 2024-2025 | Tepezza |
| Dompe US, INC. | $1,112.22 | 2021-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $709.77 | 2019-2025 | Cequa |
| Rxsight INC | $613.21 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Oyster Point Pharma, INC. | $575.25 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Allergan, INC. | $466.96 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $462.17 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $459.69 | 2022-2023 | Tepezza |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $394.41 | 2019-2023 | Vabysmo |
| Mallinckrodt Hospital Products INC. | $380.76 | 2020-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $366.28 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $339.12 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $337.07 | 2024-2025 | Purified Cortrophin Gel |
| Kala Pharmaceuticals, INC. | $320.97 | 2021-2022 | |
| Dutch Ophthalmic, USA | $206.76 | 2020-2025 | Tissueblue, Eva, Combined Machine |
| Regeneron Healthcare Solutions, INC. | $131.83 | 2025 | Eylea Hd |
| Ivantis, INC | $124.57 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $116.57 | 2019 | |
| Beaver-Visitec International, INC. | $115.36 | 2025 | |
| Apellis Pharmaceuticals, INC. | $112.48 | 2024 | Syfovre |
| Galderma Laboratories, L.P. | $99.77 | 2019 | |
| Biotissue Holdings INC. | $89.75 | 2025 | |
| Shire North American Group INC | $48.88 | 2019 | |
| New World Medical,INC. | $29.29 | 2025 | Streamline, Via360, Ahmed Glaucoma Valve |
| Heidelberg Engineering, INC. | $25.42 | 2019 | |
| Staar Surgical Company | $16.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.